Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

Markets & Finance

Roth Capital Slashes Cutera to Buy from Strong Buy


Roth Capital downgraded Cutera (CUTR) to buy from strong buy, after the cosmetic treatment company on Monday posted fourth quarter results.

Analyst Mark Taylor says Cutera announced its revenues were up 49% year over year year, among other things. Its balance sheet ended 2005 with $92 million in cash. Taylor raised his 98 cents 2006 earnings per share estimate to $1.00, and his $1.27 2007 estimate to $1.34. But he maintains a 12-month stock price target of $35, given remaining uncertainty over Cutera's upcoming May 2006 patent trial.


LIMITED-TIME OFFER SUBSCRIBE NOW
 
blog comments powered by Disqus